FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to pharmacology, and can be used as a preventive and therapeutic agent for attention deficit hyperactivity disorder. Only active ingredient of which is (-)-1-(benzofuran-2-yl)-2-propylaminopentane or its pharmacologically acceptable acid addition salt. Also disclosed is a method of treating attention deficit hyperactivity disorder (ADHD).
EFFECT: group of inventions widens the possibility of selecting a drug therapy for ADHD.
2 cl, 4 dwg, 1 ex
Authors
Dates
2019-12-11—Published
2014-12-15—Filed